1. Profile

Al Hikma Pharmaceuticals

Last Updated:
  • 70.100 USD
  • 0.000
  • 0.00%
الحكمة للصناعات الدوائية
الحكمة
Symbol : HIK
ISIN : US4312882081
52-Week Range : 0.000 - 70.100
Turnover Ratio : 0.00
Market : Nasdaq Dubai
Sector : --
Industry : Pharmaceuticals
Sub-Industry :

Basic Information

  • Activity :
    Hikma Pharmaceuticals PLC is engaged in the development, manufacture and marketing of a broad range of generic and in-licensed pharmaceutical products in solid, semi-solid, liquid and injectable final...
  • Industry Group :
    Pharmaceuticals, Biotechnology & Life Sciences
  • Sub-Industry :
  • ISIN :
    US4312882081
  • Contact Person :
    Hana Ramadan
  • Established On:
    01-Jan-1978
  • Stock Listing On :
    26-Apr-2006
  • No of Employees :
    --
  • Outstanding Shares :
    231,472,930
  • Free Float Shares :
  • Par Value :
  • Paid Capital :
  • Market Cap :
  • Authorized Capital :

Indices Membership

Data Not Available
Hikma Pharmaceuticals PLC
1 New Burlington Place, London W1S 2HR
T : +44 2073992760
F : +44 2073992761
www.hikma.com
investors@hikma.uk.com

Management

Title Name As Of
Chairman: Said Darwazah 2014
Board Member: Patrick Butler 2014
Sigurdur Olafsson 2018
Pamela Kirby 2014
Mazen Darwazah 2005
Ali Al Husry 2005
Ronald Goode 2006
Robert Pickering 2011
Nina Henderson 2017
Cynthia Schwalm 2019
Douglas Hurt 2020

Reports

Date Title File
2019 Hikma Pharmaceuticals Annual Financials Report 2018
2019 Hikma delivers strong 2018 results and makes good strategic progress to position for future growth
2018 Hikma reports strong 2018 interim results and raises full year guidance
2018 Hikma reports 2017 full year results
2017 Al Hikma Pharmaceutical Company achieves strong financial performance and strategic progress in 2016
2016 Hikma Pharmaceuticals Annual Financials Report 2015
2016 Hikma Pharmaceuticals Annual Financials Report 2015
2015 North Africa Holding to fully exit from EIMC United Pharma
2015 Hikma Pharmaceuticals Quarterly Financials Report Q2 2015
2015 Hikma acquires Roxane Laboratories
2015 Hikma Pharmaceuticals PLC Voting Rights and Capital
Check our coverage for
Check The List